{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:23:35Z","timestamp":1794432215327,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:00:00Z","timestamp":1794355200000},"content-version":"vor","delay-in-days":194,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijcard.2026.134190","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:20:29Z","timestamp":1769127629000},"page":"134190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SGLT2 inhibitors and risk of new-onset left bundle branch block in heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"450","author":[{"given":"Marco","family":"Zuin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Canovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Serenelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fucili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2026.134190_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.25801","article-title":"Left bundle branch block as a risk factor for heart failure","volume":"8","author":"Thein","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ijcard.2026.134190_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejheart.2006.04.011","article-title":"Left bundle branch block as a risk factor for progression to heart failure","volume":"9","author":"Zannad","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134190_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ahj.2020.10.053","article-title":"Left bundle-branch block is associated with a similar dyssynchronous phenotype in heart failure patients with normal and reduced ejection fractions","volume":"231","author":"Friedman","year":"2021","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2026.134190_bb0020","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cvr\/cvae047","article-title":"SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits","volume":"120","author":"Preda","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2026.134190_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12933-025-02767-9","article-title":"The effects of SGLT2i on cardiac metabolism in patients with HFpEF: fact or fiction?","volume":"24","author":"Cinti","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcard.2026.134190_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2025.103149","article-title":"SGLT2 inhibitors and cardiac fibrosis: a comprehensive review","volume":"50","author":"Karakasis","year":"2025","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134190_bb0035","doi-asserted-by":"crossref","first-page":"30764","DOI":"10.1038\/s41598-024-80829-w","article-title":"Effects of empagliflozin and dapagliflozin in alleviating cardiac fibrosis through SIRT6-mediated oxidative stress reduction","volume":"14","author":"Ma","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcard.2026.134190_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108861","article-title":"Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure","volume":"270","author":"Armillotta","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2026.134190_bb0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.120.052048","article-title":"Sodium-glucose cotransporter 2 inhibitors in patients with heart failure with reduced ejection fraction: the heart and kidney working better together","volume":"143","author":"Carnicelli","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.134190_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101615","article-title":"Sodium-glucose Cotransporter-2 inhibitors and arrhythmias: a Meta-analysis of 38 randomized controlled trials","volume":"4","author":"Jaiswal","year":"2025","journal-title":"JACC Adv."},{"issue":"44","key":"10.1016\/j.ijcard.2026.134190_bb0055","first-page":"3627","article-title":"Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"2023","author":"TA","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.134190_bb0060","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/ejhf.1972","article-title":"PARADIGM-HF and ATMOSPHERE committees and investigators. Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE","volume":"22","author":"Kristensen","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134190_bb0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00395-025-01115-y","article-title":"Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium","volume":"120","author":"Wang","year":"2025","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134190_bb0070","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1093\/eurheartj\/ehad389","article-title":"Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction","volume":"44","author":"Pandey","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.134190_bb0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s40001-025-02834-7","article-title":"Impact of SGLT2 inhibitors on myocardial fibrosis in diabetic HFpEF: a longitudinal study","volume":"30","author":"Albulushi","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.ijcard.2026.134190_bb0080","doi-asserted-by":"crossref","first-page":"1291450","DOI":"10.3389\/fcvm.2023.1291450","article-title":"The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy","volume":"10","author":"Su","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2026.134190_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011646","article-title":"Proving SGLT2 inhibitor-mediated improvement in cardiomyocyte energetics: beyond a reasonable doubt?","volume":"17","author":"Filipp","year":"2024","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134190_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ejhf.3411","article-title":"Association of ventricular-arterial coupling with biomarkers involved in heart failure pathophysiology - the STANISLAS cohort","volume":"27","author":"Holm","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134190_bb0095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12933-024-02312-0","article-title":"The potential anti-arrhythmic effect of SGLT2 inhibitors","volume":"23","author":"Duan","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcard.2026.134190_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ahj.2020.10.053","article-title":"Left bundle-branch block is associated with asimilar dyssynchronous phenotype in heart failure patients with normal and reduced ejection fractions","volume":"231","author":"Friedman","year":"2021","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2026.134190_bb0105","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacbts.2021.06.002","article-title":"Device-based solutions to improve cardiac physiology and Hemodynamics in heart failure with preserved ejection fraction","volume":"6","author":"Rosalia","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.ijcard.2026.134190_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/DMSO.S233538","article-title":"Extraglycemic effects of SGLT2 inhibitors: a review of the evidence","volume":"13","author":"Bonora","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.ijcard.2026.134190_bb0115","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134190_bb0120","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/ejhf.2249","article-title":"Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial","volume":"23","author":"Solomon","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134190_bb0125","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jacc.2025.08.036","article-title":"Central adiposity or hypertension: which drives heart failure with a preserved ejection fraction?","volume":"86","author":"Packer","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134190_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021660","article-title":"Coronary artery disease and heart failure with preserved ejection fraction: the ARIC study","volume":"11","author":"John","year":"2022","journal-title":"J. Am. Heart Assoc."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326000380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326000380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:55:03Z","timestamp":1794430503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527326000380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":26,"alternative-id":["S0167527326000380"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134190","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibitors and risk of new-onset left bundle branch block in heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134190"}}